Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116283527B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116283527B reveals nickel-catalyzed tetralone synthesis offering high purity and cost efficiency for scalable pharmaceutical intermediates manufacturing supply chains.
Novel nickel-catalyzed route for tetralone skeletons offering high ee values and cost-effective manufacturing for pharmaceutical intermediates.